Driven by personal experience, Zak Williams is helping shape an A.I. platform designed to improve how mental illness is diagnosed and treated. Elizabeth Weinberg

As ChatGPT moves to encompass the full scope of health care, others are taking a more nuanced approach. One is Headlamp Health, whose new intelligence platform, Lumos AI, aims to advance a research field that has long stalled for drug developers, clinical trial researchers and clinicians working to solve complex mental health challenges in even more complex patients.

Sign Up For Our Daily Newsletter

Sign Up

Thank you for signing up!

By clicking submit, you agree to our terms of service and acknowledge we may use your information to send you emails, product samples, and promotions on this website and other properties. You can opt out anytime.

With an advisory board that includes investor, entrepreneur and mental health advocate Zak Williams—the son of the late actor Robin Williams—Headlamp officially launched Lumos on Jan. 7. The platform is designed as a coordinated set of agentic A.I. layers meant to bring precision medicine to a space that has long lacked it.

“I never thought I’d go into the mental health space,” Williams told Observer. “But after my father died by suicide, and I was diagnosed with complex post-traumatic stress disorder, generalized anxiety disorder and depression, I found myself in need of solutions.”

That experience led Williams to work with Headlamp Health, where he advises on both the technology and its market positioning. He saw not only a need for reinvention in psychiatry, but also an opportunity to help others where he could.

Erwin Estigarribia, CEO of Headlamp Health, who previously focused on oncology and cardiology technology, has his own reasons for entering the psychiatry tech space. “I was exposed to the mental health side of medicine through family members and personal........

© Observer